1. Home
  2. AVDL vs HBNC Comparison

AVDL vs HBNC Comparison

Compare AVDL & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • HBNC
  • Stock Information
  • Founded
  • AVDL 2015
  • HBNC 1873
  • Country
  • AVDL Ireland
  • HBNC United States
  • Employees
  • AVDL N/A
  • HBNC N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • HBNC Major Banks
  • Sector
  • AVDL Health Care
  • HBNC Finance
  • Exchange
  • AVDL Nasdaq
  • HBNC Nasdaq
  • Market Cap
  • AVDL 861.4M
  • HBNC 708.6M
  • IPO Year
  • AVDL 1996
  • HBNC N/A
  • Fundamental
  • Price
  • AVDL $12.75
  • HBNC $15.22
  • Analyst Decision
  • AVDL Strong Buy
  • HBNC Hold
  • Analyst Count
  • AVDL 7
  • HBNC 2
  • Target Price
  • AVDL $19.00
  • HBNC $18.00
  • AVG Volume (30 Days)
  • AVDL 1.2M
  • HBNC 210.6K
  • Earning Date
  • AVDL 08-07-2025
  • HBNC 07-23-2025
  • Dividend Yield
  • AVDL N/A
  • HBNC 4.26%
  • EPS Growth
  • AVDL N/A
  • HBNC 170.68
  • EPS
  • AVDL N/A
  • HBNC 1.17
  • Revenue
  • AVDL $221,075,000.00
  • HBNC $211,581,000.00
  • Revenue This Year
  • AVDL $56.78
  • HBNC $47.48
  • Revenue Next Year
  • AVDL $30.46
  • HBNC $4.01
  • P/E Ratio
  • AVDL N/A
  • HBNC $12.85
  • Revenue Growth
  • AVDL 132.35
  • HBNC 17.55
  • 52 Week Low
  • AVDL $6.38
  • HBNC $12.70
  • 52 Week High
  • AVDL $17.30
  • HBNC $19.18
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 76.98
  • HBNC 45.06
  • Support Level
  • AVDL $10.79
  • HBNC $14.98
  • Resistance Level
  • AVDL $14.23
  • HBNC $15.45
  • Average True Range (ATR)
  • AVDL 0.59
  • HBNC 0.41
  • MACD
  • AVDL 0.14
  • HBNC -0.09
  • Stochastic Oscillator
  • AVDL 61.15
  • HBNC 27.42

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

Share on Social Networks: